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Abstract
Despite the proven efficacy and cost-effectiveness of contemporary cardiovascular rehabilitation programmes, the
referral to/uptake of and adherence to cardiovascular rehabilitation remains inadequate. In addition, heterogeneity
persists amongst different cardiovascular rehabilitation centres in Europe, despite the available scientific documents
describing the evidence-based rehabilitation format/content. This position statement was elaborated by the Secondary
Prevention and Rehabilitation (SP/CR) section of EAPC. It defines the minimal and optimal cardiovascular rehabilitation
standards. In addition, it describes the relevant quality indicators of cardiovascular rehabilitation programmes to date.
Compliance of European cardiovascular rehabilitation centres with these standards will improve cardiovascular reha-
bilitation process standardization in Europe and hence increase the quality of cadiovascular rehabilitation programmes.
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1. Introduction
Cardiovascular diseases still remain one of the main
causes of mortality and morbidity in Europe.1 After
significant improvement in the availability of novel
pharmacological treatments, percutaneous cardiac
interventions (PCIs) and cardiac surgery, it is now par-
amount to invest also in the improvement of cardiovas-
cular rehabilitation (CR) programmes.2
CR started as an exercise-based programme, sup-
ported by its demonstrated benefits.3 Evolving over
time, it is currently a comprehensive patient-tailored
programme that aims to improve the patient’s physical,
psychological, social and work condition, after an
acute cardiac event or in the context of chronic cardio-
vascular disease with risk factors or incomplete revas-
cularization.4 Comprehensive CR should encompass a
multidisciplinary intervention, including exercise train-
ing, risk factor control, psychosocial counselling,
smoking cessation, patient education and vocational
reintegration.4
Previous data, including recent meta-analysis have
shown the efficacy of CR3,5–7 to reduce mortality, myo-
cardial infarction (MI) and improve functional capacity,
psychosocial wellbeing and quality of life in coronary
artery disease patients. Several benefits extend to
patients with heart failure (HF) and patients with devi-
ces8–10 or submitted to cardiac surgery,11 among others.
In addition, CR is considered cost-effective in cardiovas-
cular disease.12 The European Society of Cardiology
(ESC) and the American Heart Association (AHA)/
American Association of Cardiovascular and
Pulmonary Rehabilitation (AACVPR), classify CR as
a therapeutic intervention with class I indication (man-
datory), based on the highest levels of scientific evidence
(A and B, according to the indications) in multiple car-
diac conditions. The main candidates for this interven-
tion are coronary patients (with or without PCI), HF
patients (with orwithout devices) andpatients submitted
to cardiac surgery (including revascularized, valvular
and cardiac transplant patients).13
Despite its proven efficacy, some important gaps
and challenges remain ahead of us in CR. As evidenced
by the EUROpean Action on Secondary Prevention
through Intervention to Reduce Events
(EUROASPIRE) study IV14 and V,15 less than 50%
of eligible coronary patients (43% and 34%, respective-
ly) participate in CR programmes after an acute event,
which widely differ in content/duration and intensity
between the different European countries. Barriers to
implementation are present at different levels: the
patient, the physician and the health system.4 Specific
interventions may increase CR enrolment, adherence
and completion as shown in the Cochrane systematic
review and meta-analysis regarding intervention to
promote patient’s utilization of CR,16 though the qual-
ity of evidence was low to moderate due to heteroge-
neity of the interventions used, among other factors.
More research is needed, particularly to discover the
best ways to increase programme completion. CR uti-
lization needs to be promoted, always assuring minimal
criteria of the CR programmes. CR, as with all medical
interventions, will only produce its proven benefits if
correctly performed according to tested protocols evi-
denced through rigorous peer-reviewed studies.
The European survey on cardiac rehabilitation per-
formed in 2010, European Cardiac Rehabilitation
Inventory Survey (ECRIS),17 including 28 European
countries, indeed showed that fewer than half of eligi-
ble patients benefit from CR in most European coun-
tries, with high heterogeneity in CR provision/content
post-MI across Europe (3% to more than 50% CR
utilization rate). This has also recently been confirmed
by the online data of the project ‘Country of the
month’ of the European Association of Preventive
Cardiology (EAPC), with 10% to >75% % for CR
uptake after MI.18 Data from a recent global CR
survey, show that across all Europe, there was an
unmet regional need of 3,449,460 CR places
annually, attesting that European CR capacity must
be augmented.19 In the Extra-HF Survey20 it was
observed that almost 40% of the surveyed cardiac
centres in Europe that deal with HF patients did not
implement exercise training programmes in these
patients and furthermore only half of the HF patients
admitted to general cardiology centres were proposed
to attend exercise programmes, due to the lack of
resources or logistics.
The use of minimum standards for the evaluation of
the quality of CR has been tested elsewhere21 and
accreditation has been implemented in other countries
such as the USA22 and the UK23 with varying levels of
success.
The EAPC CR accreditation programme builds on
previous minimum standard approaches by adding
optimal quality indicators that serve as a vehicle to
accelerate translation of scientific evidence into clinical
practice. The metrics developed by the EAPC are
intended to provide CR centres with a way to be
acknowledged when providing high-level quality of
care. In addition, this serves to encourage European
CR centres to improve the standard of care delivery
up to good clinical practice standards. The EAPC
Secondary Prevention and Rehabilitation (SP/CR)
Section developed the accreditation programme to
benchmark and improve the quality of care for patients
eligible for CR in the European CR centres. The pre-
sent paper describes minimal and optimal CR quality
standards and auditing processes in CR. Only through
rational and balanced distribution of a greater number
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of CR centres, with programmes achieving the criteria
defined in these recommendations, can we be guaran-
teed that all cardiovascular patients have equality of
access to an evidence-based, cost-effective and safe
intervention. The EAPC accreditation SP/CR pro-
gramme criteria defined in this position paper, are con-
fined to phase 2 of CR.
The overarching aim of the EAPC accreditation pro-
gramme project in CR is to improve secondary preven-
tion for all eligible patients. More specifically and using
the SMART (Specific, Measurable, Attainable,
Relevant, Timely) principles:24 the goal is to provide
formal accreditation on an European level, to those
CR centres that meet at least the defined minimal stand-
ards. The principal aims of the EAPC SP/CR section
accreditationprogrammemaybe further summarised as:
• Specific: to provide standards and key performance
indicators (KPIs) enabling formal accreditation of
those European CR centres, that meet at least the
defined minimal CR requirements.
• Measurable: documentation of the standards being
met by the European CR centres, participating in
the EAPC accreditation programme will enable
measurement and reporting of national trends in
the quality of care delivered in the respective
European CR centres.
• Attainable: through achieving KPIs and standards
bring all CR programmes up to an evidence-based
level of performance associated with improved
patient benefit.
• Relevant: residents of the EU are entitled and
should be reassured that the treatment and care
they receive through CR is of good quality, accessi-
ble and equitable no matter where they live.
• Time-bound: the EAPC completed its feasibility/
pilot phase and has already formally accredited
several centres.
II. Methodology
In developing the EAPC centre accreditation for SP/CR,
the EAPC SP/CR section reviewed evidence-based
guidelines and statements that would potentially
inform the construct/content of the accreditation pro-
gramme. Clinical practice guidelines and scientific state-
ments in recent years, that were demonstrative of the
application of SP/CR to different cardiovascular
conditions and/or most directly contributed to the
development of this accreditation programme descrip-
tion, are depicted in Table 1.13,25–43 By publishing the
minimal and optimal CR standards, defined as part of
this EAPC accreditation programme, the adoption of
these standards is encouraged. In addition, it is hoped
to facilitate the collection and analysis of data that reflect
the current status of care delivery on an European-wide
scale, in order to being able to focus future improvement
efforts on the areas that need it the most.
Cardiovascular rehabilitation (CR) standards and
quality indicators are defined in this document.
Minimal CR standards are distinguished from optimal
CR standards. Both structure- and process-based
metrics are defined. Quality assessment is based on
the definition of quality metrics.
Minimal CR standards are mandatory for the
European CR centres to have if they want to become
accredited. Optimal CR standards are not mandatory,
but highly recommended to further improve the deli-
vered care. Both the minimal and optimal CR
standards are based on predefined structure- and
process-based metrics. Structure-based metrics quanti-
fy both the human and infrastructural resources, that
are needed to ascertain a high-quality standard of CR
care delivery. The availability of adequate personnel,
equipment and CR room environment is a sine qua non
for the successful implementation of high quality CR.
Process-based metrics are defined as the necessary core
components of the process of CR care delivery, cover-
ing all relevant dimensions of secondary prevention.
Quality metrics and/or quality indicators are measure-
ments that reflect the quality of delivered care.
III. Minimal and optimal standards in
Europe
To start, it is clear that all eligible cardiac patients should
be referred to CR. These include mainly patients with: (a)
acute coronary syndrome26,29 (Class I indication), (b) PCI
and/or myocardial revascularization surgery26,27,29,34
(Class I indication), (c) stable coronary artery disease27
(Class I indication), (d) HF28,31,33,37,39,41,44 (Class I indi-
cation), (e) cardiac transplant,45,46 (f) left ventricular assist
device and/or other implanted devices (including pace-
makers, internal cardioverter defibrillators, cardiac
resynchronizers therapy),37,39,41,47,48 (g) cardiac surgery
(including valvular surgery, percutaneous valvular pros-
thesis or Mitralclip)49–52 and (h) high cardiovascular risk
factor profile (diabetes mellitus, arterial hypertension,
dyslipidaemia, severe obesity).30,42
The timing of CR has a significant impact on fit-
ness53 and psychological outcomes.54 CR should ideal-
ly begin during in-hospital stay (phase 1), proceed after
discharge to early ambulatory or residential (phase 2)
and be maintained for life (phase 3) in a continuum
process. In some cases, patients are not hospitalized,
like high cardiovascular risk patients without acute
events, and enter directly into phase 2, which may be
ambulatory (out-patient), residential (in-patient) or
home-based, according to the health systems and
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legacy in different European countries.3 It can be per-
formed in the hospital setting, a specialised CR centre
or, in some cases, at the patient’s home (home-based).
Phase 2 should be started as soon as possible after an
acute event.55,56 After discharge of MI and PCI
patients, it is considered optimal starting CR in the
first 14 days and minimally accepted at 15–30 days.
After Coronary Artery Bypass Grafting (CABG)
patients discharge, it is recommended, as optimal,
starting CR at 28 days (may be earlier in experienced
centres, with special care avoiding exercises that might
interfere with sternum consolidation) and minimally
accepted at 29–42 days. The duration of CR needs to
be individualised for every patient according to their
characteristics (e.g. age, physical condition, risk profile,
adherence, cardiac condition, personal choice), but
should include at least 24 sessions (minimal standard).
III.A. Structure-based metrics
Table 2 elaborates on the CR structure-based metrics,
that are defined as part of the EAPC SP/CR accredi-
tation programme. For each metric, Table 2 informs
the reader about whether the metric is perceived as
minimal and/or optimal.
III.A.a. Infrastructural structure-based metrics
Policies and procedures regarding the management of
each facility are aimed at providing a safe, functional
Table 1. Clinical practice guidelines and other clinical guidance documents.
Clinical practice guidelines
AHA/ACCF guidelines for secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic
vascular disease: 2011 Update25
2012 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation26
2013 ESC guidelines on the management of stable coronary artery disease27
2013 ACCF/AHA guidelines for the management of heart failure: a report of the American College of Cardiology Foundation/
American Heart Association Task Force on Practice Guidelines28
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment
elevation29
2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society
of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice30
2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment
of acute and chronic heart failure of the European Society of Cardiology31
2018 AHA/ACC guidelines for the management of adults with congenital heart disease. Executive summary: A report of the American
College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines32
2018 National Institute for Health and Care Excellence (NICE). Chronic heart failure: Management of chronic heart failure in adults in
primary and secondary care. Clinical guidelines33
2018 ESC/EACTS guidelines on myocardial revascularization34
2018 ESC/ESH guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of
the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)35
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for
the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)36
2019 Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert
consensus meeting report of the Heart Failure Association of the European Society of Cardiology37
Scientific statements, consensus documents and position papers
2007 AHA scientific statement. Core components of cardiac rehabilitation/secondary prevention programmes38
2010 EAPC-CR section position paper: Secondary prevention through cardiac rehabilitation: From knowledge to implementation13
2011 ESC consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and
Rehabilitation. Exercise training in heart failure: From theory to practice39
2017 The BACPR standards and core components for cardiovascular disease prevention and rehabilitation40
2019 ESC position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of
the Heart Failure Association. Exercise training in patients with ventricular assist devices: a review of the evidence and practical
advice41
2019 American Diabetes Association standards of medical care in diabetes42
2020 EAPC position paper update. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to
implementation43
ACC: American College of Cardiology; ACCF: American College of Cardiology Foundation; AHA: American Heart Association; BACPR: British
Association for Cardiovascular Prevention and Rehabilitation; CR: cardiac rehabilitation; EAPC: European Association of Preventive Cardiology; EAS:
European Atherosclerosis Society; ESC: European Society of Cardiology; ESH: European Society of Hypertension; EACTS: European Association of
Cardiothoracic Surgery; SP: Secondary Prevention; ECG: Electrocardiogram.
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Table 2. Minimal and optimal structure-based CR metrics, as defined in the European Association of Preventive Cardiology (EAPC)
SP/CR accreditation programme.
Infrastructural
Minimal
Dedicated consultation area, for medical evaluation and prescription and psychological evaluation and intervention
Exercise facilities (laboratory/room) with equipment for assessment of functional capacity, including appropriate place to perform
6MWT (12 m long hallway with markers in the corners) or other functional tests and treadmill and/or cycloergometer for standard
exercise testing
Dedicated facilities for exercise training, well ventilated, good temperature and humidity conditions, floor space approximately 4 m2
per patient
Equipment for assessment of clinical status: sphygmomanometer, ECG, chemistry analysis, urine analysis (analysis may be outsourced)
Equipment (via outsourcing) for assessment of left ventricular function: echocardiography
Equipment (via outsourcing) for assessment of arrhythmias: ambulatory ECG Holter monitoring
Equipment for conducting an exercise training programme: for aerobic and strength training
Equipment for cardiac monitoring
The means, on site, to summon assistance in case of emergency in the exercise room to start life support: automated external
defibrillator, material for intubation and ventilation, material for intravenous drugs administration
Emergency services available or <10 min away
List of medical equipment and devices in use including details on maintenance and validity (if necessary)
Optimal
Specific education and counselling area for group interventions
Electronic patient files
Investigation room (e.g. for echocardiography)
Dedicated exercise facilities (laboratory/room) with equipment for cardiorespiratory exercise testing
Resting/dress room with separate toilets and shower facilities
Lockers to safely store the patients’ belongings while training
Equipment for assessment of left ventricular function: echocardiography and other imaging equipment depending on circumstances
and type of patients
Equipment for assessment of arrhythmias: ambulatory ECG Holter monitoring
Equipment for assessment of psychosocial status: licensed tests and screening instruments (ideally computerised)
Human resources
Minimal
A medical director with cardiology training is responsible for the oversight of programme policies and medical procedures. The
medical director can have the role of programme director as well
Multidisciplinary team: cardiologist, nurse, exercise specialist, nutritionist
All professionals must have a written employment/agreement contract
For every profession within the centre an updated job description is available
The director of the clinic has attended a congress/symposia in the field of secondary prevention and/or cardiac rehabilitation, within
the last 2 years, organised by recognised organisations such as the national cardiac societies or EAPC/ESC
Of the staff, 90% have completed a specialization course or attended a congress/symposia in the field of secondary prevention and/or
CR, within 3 years, organised by recognised organisations such as the national cardiac societies or EAPC/ESC
All professionals directly involved in patient care possess a valid (less than 4 years old) certificate of cardio-pulmonary resuscitation
training
Optimal
There is a programme director: any member of the team, with good organizational, management and interpersonal skills may have this
role, to ensure proper organisation of the programme and consistency of policies and procedures with evidence-based guidelines
One of the staff members recently (actively) contributed to a relevant congress or peer-reviewed medical journal
Exclusively dedicated multidisciplinary team covering a wide range of schedules during the day
Multidisciplinary disciplinary team includes psychologist
Multidisciplinary team includes additional healthcare professionals: diabetologist, psychiatrist, social worker
Centre requirements
Minimal
Protocol handling the complaints and list of complaints (it might be a general one from the hospital/clinic)
(continued)
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and effective environment.4 The components of these
facilities should include (a) planning of space utiliza-
tion, (b) acquisition of equipment and maintenance, (c)
reduction and control of environmental hazards and
risks, (d) maintenance of safe conditions (there must
be emergency access to all patient areas, and floor
space must allow easy access for personnel and equip-
ment) and patient comfort, (e) climate control (ade-
quate temperature and humidity).4
A specific space and equipment for evaluating func-
tional capacity are necessary for CR. The existence of
an appropriate place to conduct a six-minute walk test
(6MWT) (12 m hallway with markers in the corners) or
an alternative test as incremental shuttle walk test
(ISWT), for those patients who are not able to under-
take an exercise test,57 and a room (or laboratory) with
treadmill and/or cycloergometer, for standard exercise
testing performance to allow evaluation of patients car-
diac risk and exercise prescription, are considered as
minimal criteria. If the CR centre does not possess
exercise test facilities, the standard exercise test must,
as an alternative, be conducted via outsourcing. The
existence of cardiorespiratory testing equipment in
the exercise facilities is considered as an optimal
criterion.
A gymnasium with adequate equipment for exercise
sessions, waiting room, meeting room, consultation
room, counselling area for group interventions and
separate toilets and shower facilities is necessary for
centre-based phase 2. After phase 1 early mobilization,
phase 2 CR training should offer different activities,
whenever possible, with the use of various ergometers
and material for functional training, adapted to the
needs of the population to treat. Monitoring must be
available for cardiac patients considered high risk
for exercise (see below III.B.a.1. Patient evaluation,
risk assessment and risk factors identification). The
low-risk patients do not need monitoring in most of
the cases.
Regular audit is essential and aims to demonstrate
that programmes are achieving the desired clinical out-
comes, and it enables local evaluation and national
comparison. Every CR service should be audited
locally (against agreed service standards) and also reg-
istered with their respective national audit programme.
Data on clinical outcomes and patient satisfaction plus
service performance should be routinely collected.
Data collection instruments are necessary to prospec-
tively review the programme’s internal procedures with
the ultimate goal of enhancing the quality improvement
process. Evaluation of performance dimensions,
involve timeliness, effectiveness, continuity, safety, effi-
ciency and evaluation of the patient.3
III.A.b. Human resources structure-based metrics
An optimal standard is the existence of a full-time ded-
icated multidisciplinary team operating in a designated
area.4
The members of the team and a dedicated space
should be available to cover diversified schedules
during the day, from early morning to late evening,
in order to overcome timetable barriers. The composi-
tion of the multidisciplinary team may differ, according
to countries and availability, but it has to respect the
knowledge and competences necessary for achieving
the main central components of CR, being mandatory
to include a cardiologist, an exercise specialist (physio-
therapist or exercise physiologist, most frequently), a
nutritionist and a nurse, as minimal standards. The
optimal criteria would add psychologists, social work-
ers, administrative personnel and other specialists for
specific consultation and advise. These professionals
may be available on request. Besides, the professional
certification, and specific competence on CR, in some
countries, the team members need to be trained to their
task. Education and preparation of the team members
according to their roles in the CR programme is
fundamental.
It is important to define for each professional
employee:4 (a) the specific professional qualifications,
(b) the educational training needed, (c) the responsibil-
ity for delivering services of appropriate standard of
care, (d) the general duties (emergency procedures, liai-
son with other health care providers, basic skills in data
collection and documentation, staff training and
Table 2. Continued
Protocol handling the adverse events and list of adverse events (it might be a general one from the hospital/clinic)
Organizational team meetings on a 2 weeks basis (which are documented)
Optimal
Organizational team meetings on a weekly basis (which are documented)
Strategic plan, not more than 5 years old (including future perspectives, objectives, care programmes, patient safety and enhancement
of quality of care)
Annual evaluation report to monitor service delivery and outcomes
6MWT: six-minute walk test; ESC: European Society of Cardiology.
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performance reviews), (e) the specific duties (patients’
counselling, interactive discussion groups, exercise ses-
sions supervising, processing referrals, programmes’
management, coordinating programmes, discharge
planning and follow-up).
The role of the programme medical coordinator/
director should be covered optimally by a cardiologist
with adequate training in CR.4 He/she is encouraged to
participate in EAPC training courses in CR (or na-
tional equivalents such as British Association for
Cardiovascular Prevention and Rehabilitation,
BACPR, training courses for UK programmes), to
ascertain his/her competence in this regard. In the
case when this is not possible, as might happen in
some countries, the minimal criteria is that another
medical doctor with cardiology and CR experience
should take the coordination role. He/she will be
responsible for organising the programme (safeguard-
ing its effectiveness and safety) and supervise the CR
team (guaranteeing that all the team members hold
certification and are trained in basic life support and
resuscitation and are operating well in their tasks). He/
she should evaluate the patient’s evolution, the achieve-
ment of all CR programme outcomes, supervise the
quality of care offered by the team, guarantee the
implementation of legislation and perform periodic
reports on the CR activity.
The individual prescription of aerobic exercise inten-
sity should optimally be determined by a cardiologist
with training in exercise programmes, based in the
results of an exercise test.43 In some countries, exercise
prescription to cardiac patients may be performed by
exercise specialists with vast experience in cardiovascu-
lar disease patients, supported and validated by CR
cardiologists, who have the responsibility for patient’s
safety (minimal standard). The exercise specialist task
is to apply the prescription during the programme exer-
cise sessions, informing the prescribing cardiologist of
the way the patient and himself perceive the intensity,
as well as the clinical response regarding the type of
prescribed activity. The exercise specialist, physiother-
apist or exercise physiologist, coordinates the exercise
training under medical supervision and is responsible
for the diversification and progression of training. The
relationship between the number of exercise professio-
nals and the number of patients may be different
according to programmes, patient’s clinical complexity
and professional experience.58 It is suggested as opti-
mal the ratio of one exercise specialist for 5–10 low- or
intermediate-risk patients/session.58 The ratio for
high-risk patients should be higher, optimally one pro-
fessional to 2–3 patients, according to patient’s risk
severity.2 There should be always two healthcare pro-
fessionals in the exercise room, for the sake of possible
complications during exercise.
During the training sessions, in most cases, the car-
diologist does not need to be continuously present in
the gymnasium, however he/she will be obligated to be
nearby, easily contactable and available to rapidly
identify and intervene in case of complications and to
resolve questions regarding the training or clinical
problems, including adjustment of pharmacological
therapy.2 In the absence of a cardiologist, health per-
sonnel with adequate training in interpretation of elec-
trocardiographic tracing should always be present.
Trained personnel should be immediately available
with adequate equipment to respond to medical
emergencies.
Nutritionists will evaluate nutritional status and will
intervene on weight modification and risk factor ma-
nagement, in conditions like diabetes and dyslipidae-
mia. Psychologists will do the screening of the patients
for depression, anxiety, stress, hostility, personality dis-
turbances and sexual dysfunction. They will intervene
using interview and specific techniques, directing to a
psychiatrist those patients who need this type of eval-
uation/intervention.
The CR team might need to ask for support from
other specialist doctors, such as internists, endocrinol-
ogists or pneumologists, to manage the different
comorbidities present in the patients. Cardiologists,
nurses and nutritionists will have the greatest role in
education, being responsible for nutritional, physical
activity and exercise/sports advice. Social workers will
help with vocational counselling and social integration
and support.
All clinical data should be digitally stored in a spe-
cific CR database, optimally in connection with all the
clinical information and ideally in connection to the
other national CR databases.
It is important to provide an organizational chart,
presenting the number of people within each profes-
sional discipline in the team, the number of permanent
or temporary consultants and the staff to patient ratio.
While more than one member of the team can share
more than only one task, some tasks require specific
skills and training and should be performed by an espe-
cially designated health professional. Determination of
the tasks attribution and responsibilities in advance,
will avoid misunderstanding and tension in the team.
III.A.c. Centre requirements
Regular meetings are important to facilitate communi-
cation between team members and to provide oppor-
tunities to discuss complex clinical cases and evaluate
the ongoing programme. Such meetings should occur
every 2 weeks (minimal) or weekly (optimal), and
should be attended by all team members. The centre
will need to have protocols for handling adverse events
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and complaints (minimal criteria) and should have an
updated strategic plan, as well as to perform annual
evaluation of delivery and outcomes (optimal criteria).
III.B. Process-based metrics
Table 3 elaborates on the CR process-based metrics,
that are defined as part of the EAPC SP/CR
Accreditation Programme. For each metric, Table 3
informs the reader on whether the metric is perceived
as minimal and/or optimal. All of the minimal criteria
are essential to a CR programme and need to be
observed. The remaining criteria will improve the pro-
gramme quality but may not be present.
III.B.a. Components of Cardiac Rehabilitation
III.B.a.1. Patient evaluation, risk assessment and risk factors
identification
• Clinical history including risk factors screening, car-
diovascular atherosclerotic risk assessment, comor-
bidities, disabilities, psychological stress, vocational
situation, physical activity level, symptoms intensity
(New York Heart Association, Canadian Cardiac
Society), physical examination
• Exams including ECG, echocardiogram, symptom-
limited exercise testing (6MWT if exercise testing is
not possible), blood testing, Holter-24-hour
Table 3. Minimal and optimal process-based cardiac rehabilitation (CR) metrics, as defined in the European Association
of Preventive Cardiology (EAPC) CR accreditation programme.
Minimal
Programme protocols with duration 24 sessions
Patient evaluation and risk factors identification (see III.B.a.1. in text)
Exercise risk assessment (see III.B.a.1. in text)
Adherence to medication counselling
Physical activity counselling (see III.B.a.2. in text)
Prescription of exercise training (see III.B.a.3. in text)
Nutritional counselling (see III.B.a.4 in text)
Limitation of alcohol consumption counselling (see III.B.a.4. in text)
Weight control management (see III.B.a.5. in text)
Lipid management (see III.B.a.6 in text)
Blood pressure monitoring and management (see III.B.a.7. in text)
Diabetes management (see III.B.a.8. in text)
Smoking cessation counselling (see III.B.a.9. in text)
Limitation of alcohol consumption counselling
Psychosocial management (see III.B.a.10 in text)
Multidisciplinary team educational meetings for patients every two weeks
CR results evaluation (see III.B.a.14 in text)
Plan at discharge and long-term approach, containing a structured follow-up (i.e. coaching by phone, consultations, mails
and posts) and relevant contact information (see III.B.a.13. in text)
Written and/or digital health behaviour and risk factor modification (see III.B.a.12. in text)
Long-term approach regarding physical activity (see III.B.a.13. in text)
Protocols for exercise programmes with emergency protocol (see III.B.a.3. in text)
Protocols of delivered care available and up to date (i.e. adjusted to the most recently published version of the European
guidelines on cardiovascular disease prevention in clinical practice)
Optimal
Programme protocols duration 36 sessions
Driving, flying and sports counselling
Sexual counselling
Vocational counselling and support (see III.B.a.11. in text)
ECG monitoring when appropriate (essential for high-risk patients)
Alternative programmes: supervised or self-delivered) such as: cardiac tele-rehabilitation, facilitated home-based training
sessions, Web-based training sessions, community based training
System in place to identify and invite all patients with an indication for secondary prevention and CR (e.g. automatic
referral)
Multidisciplinary team educational meetings for patients every week
Invitation of spouses and partners of patients to participate in health behaviour and risk factor modification education
and counselling sessions
Extensive CR to all priority groups: myocardial infarction, coronary percutaneous intervention, coronary surgery, heart
failure
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• Risk assessment for exercise
• Education on each component of CR and purpose,
and on self-monitoring and self-management
The cardiac patient has to be medically evaluated by
the cardiologist before starting any CR intervention,
which will be tailored to guarantee efficacy and safety.
Enough time is necessary for an accurate medical
evaluation of the patient, in a specific consultation
area. Although time consuming, it should include a
detailed clinical history, looking at severity of symp-
toms, stability of disease, cardiac risk factors and
comorbidities, a cardiac and general physical examina-
tion, identifying the potential presence of frailty, disabil-
ities, locomotor problems or cognitive/psychologic
dysfunction.
All coronary risk factors need to be identified and
individually targeted for interventions, pharmacologi-
cal and non-pharmacological. Hypertension, diabetes
or glucose intolerance, dyslipidaemia, smoking habits,
obesity and sedentarism are several of the modifiable
risk factors which need to be identified, quantified and
subject to definition of target values (see specific sub-
sections). An individual plan should be defined from
the beginning to achieve all target goals, which will be
monitored and periodically evaluated. If necessary,
patients can be directed to specific specialists, to
reinforce the management of risk factors control
(diabetes, smoking cessation, obesity, dyslipidaemia,
hypertension).
Functional capacity testing is obligatory for CR
planning. The patient, if capable, should always under-
take a standard exercise test, at the CR centre (optimal
standard) or outside/outsourced (minimal standard).
These tests are used for functional aerobic capacity eval-
uation, risk stratification and exercise prescription. In
the case of HF patients, cardiorespiratory exercise test
is very important for adequate exercise prescription and
prognostic purposes. The existence of this resource and
appropriate staff to conduct such tests in theCR centre is
considered an optimal standard. If the patient is not able
to undertake a standard exercise test (treadmill or cyclo-
ergometer), some functional tests might be used, like the
6MWT or ISWT. The possibility to perform these alter-
native functional tests is considered a minimal standard
for CR. These tests are useful for evaluating respective
functional improvement pre and post-CR. The 6MWT,
albeit a good test of walking ability, is not suitable for
exercise risk stratification.The reason is the impossibility
to quantify the 5 MET exercise risk threshold using the
6MWT, as brisk walking (e.g. walking at 100 m/min, 3.7
mph or 6 km/h) in a healthy adult population, is around
3.8 METS. The natural cadence and brisk walking
speeds of conventional CR patients, with a mean age
of 67 years of age with two additional comorbidities, is
likely to be less than healthy adults. This means that the
METvalues from the 6MWT(anon-incremental natural
cadence test) will not yield the necessary level of data to
guide exercise risk assessment around the 5 MET
threshold.
Also, an echocardiogram should always be performed
to evaluate, besides structural abnormalities of the heart,
cardiac systolic and diastolic function, knowing that left
ventricular systolic function is fundamental for risk strat-
ification. This exam can be done via outsourcing (mini-
mal standard) or at the CR centre (optimal standard).
Other exams, like 24-hour-Holter-monitoring (out-
sourcing or at the centre), might be necessary (e.g. sus-
picion of arrhythmias). Recent blood testing is always
necessary (i.e. lipids, glucose, haemoglobin levels) and
most frequently performed via outsourcing (minimal
standard).
Exercise risk stratification is obligatory, for safety
reasons, and will be performed by medical evaluation
using clinical, blood testing, ergometric, echocardio-
graphic and other results. There are different ways to
evaluate the cardiovascular risk of exercise.59
According to AACVPR, patients can be stratified in
three groups: high, intermediate and low risk.60 A
number of parameters are used for this effect, separat-
ing the high and low risk, respectively, as follows:
• Functional capacity (<5 METS vs 7 METS)
• Left ventricular ejection fraction (<40% vs >50%)
• Presence of cardiac symptoms/signs (present for <5
METS vs absent)
• Dysrhythmia (complex ventricular arrhythmia vs no
arrhythmia)
• Haemodynamic disturbances (present vs absent)
• Depression (present vs absent).
The timing of examinations should not delay the
planned initiation of CR.
Expected outcomes:
• Formulation of an individualised plan for a specific
disease and a specific patient for a safe tailored SP/
CR programme.
III.B.a.2. Physical activity counselling
• Recommend gradual increase in daily life activities,
minimum 2.5 h/week of moderate aerobic activity,
multiple bouts, each>10 min, 4–5 days/week
• Emphasise sedentarism as a risk factor
• Advise individualised physical activity
• Reassure regarding protocol safety
• Encourage involvement in leisure activities
• Inform the patients on risk of relapses.
Expected outcomes:
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• Increased participation in domestic, occupational and
recreational activities, improved physical activity status,
improved psychological well-being and independence.
III.B.a.3. Exercise training
• Submaximal endurance trainingwithgradual increase;
intensity prescription based on exercise testing
• Resistance training, minimum twice per week.
Regarding exercise training, exercise prescription needs
to be performed by a CR physician (cardiologist), or in
some countries initial exercise prescription is performed
by a recognised experienced exercise specialist needing
medical (CR cardiologist) support and validation (mi-
nimal criteria), in order to achieve the expected result
and not to harm the patient (see Table 4). In general,
clinicians (cardiologists) who are trained and compe-
tent in exercise prescription would oversee CR exercise
assessments and prescription.
Protocols should be adapted (tailored) to each spe-
cific patient, in order to guarantee feasibility, efficacy,
safety and adherence. Exercise should be supervised
by an exercise specialist, according to previous risk
stratification, under medical coordination, and moni-
tored in high risk patients (ECG, besides symptoms
and haemodynamic parameters monitoring).
The promotion of physical activity should be carried
out by all staff that engage with cardiac patients. In
addition to exercise training, the CR team should
agree clear physical activity goals with the patient.
Expected outcomes:
• Increased cardiorespiratory fitness, flexibility, mus-
cular endurance and strength, by at least 5–10%.
• Reduction of symptoms and attenuated physiologi-
cal responses.
• Improved psychological well-being.
III.B.a.4. Nutritional counselling
• Assessment of diet composition, eating habits and
alcohol consumption.
• Education of patient and family of dietary goals and
healthy food choices
• Integration of behaviour-change models and com-
pliance strategies in counselling sessions
• Evaluation of general nutritional status by a nutri-
tion consultant in a nutrition consultation room,
where expert advice for individual healthy choices
can be obtained.
Nutrition is essential for a healthy life, which explains
the need for nutritional evaluation, counselling and
intervention, whenever necessary (see Table 5).
Obese, hypertensive or dyslipidaemic patients need
specific counselling, information and consultation to
be reevaluated. Patients with diabetes, severe obesity,
frailty, sarcopenia or cachexia need very specific counsel-
ling and more profound and specialised intervention.
Expected outcomes:
• Modification of risk factors associated to unhealthy
or inadequate diet.
III.B.a.5. Weight control management30
Assessment:
• Nutritional status, dietary habits and physical acti-
vity habits
• Measure weight, height, body mass index (BMI) and
abdominal circumference.
Definition of normal weight (BMI 18.5-24.9 or
abdominal circumference <94 cm in man and <80
cm in women) , overweight (BMI25 and <30 or
abdominal circumference 94 and <102 cm in men
or 80 cm and <88 cm in women) and obese (BMI
30 or abdominal circumference 102 cm in men or
88 cm in women) patients.
Intervention on patients:
• Education regarding diet, exercise, behaviour
• Nutritional counselling
• Physical activity counselling
• Exercise programme (specific for weight loss)
• Psychological counselling (if necessary)
• Monitoring and coaching weight loss
Table 4. Exercise training and physical activity counselling
recommendations.
Individualised medical exercise prescription indicating an exercise
training structured programme (guaranteeing efficacy and
safety)*
Supervision of exercise training, in presence, by physiotherapist,
exercise physiologist or rehabilitation nurse, under medical
coordination
Promotion of and counselling on physical activity
*In some countries, medically supported and validated experienced
exercise specialists prescription (by cardiac rehabilitation cardiologist).
Table 5. Nutritional evaluation and counselling
recommendations.
Evaluation of nutritional status by a nutrition consultant in a
nutrition consultation room
General counselling regarding nutrition in healthy life
Intervention and counselling regarding nutritional status, like
obesity or frailty and sarcopenia, and modifiable risk factors,
like diabetes, hypertension and dyslipidaemia.
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• Obesity specialist referral (severe cases and/or
refractory to lifestyle changes).
Many CR patients are overweight or obese, placing
themselves at increased risk for diabetes. Also, weight
control is most important in those who are already
diabetic or have other major risk factors.
The majority of CR patients however fail to loose
weight during the programme, due to a combination of
factors including low energy expenditure in CR.
Weight gain after a myocardial infarction has been
associated with increased risk for diabetes.
Collaboration with hospital-based weight loss pro-
grammes with a psychologist with expertise in weight
loss might be necessary.
Expected outcomes:
• If the patient has a normal BMI (18.5–24.9), main-
tenance of the weight.
• If the patient is obese (BMI>30) or overweight (BMI
25–29.9) reduction of 5–10% of body weight in 6
months and modification of associated risk factors.
• Attainment of abdominal circumference <80 cm in
women and <94 cm in men.
• Outcomes should be adjusted for patients who start
a smoking cessation programme at the same time as
they start CR, as successful smoking cessation is
associated with weight gain.42
III.B.a.6. Lipid management36
Lipid profile assessment: total cholesterol, low-density
lipoprotein-cholesterol (LDL-C), high-density-lipopro-
tein cholesterol (HDL-C), triglycerides, apolipopro-
teins measurement
Cardiovascular atherosclerotic risk assessment:
• Very high risk: documented atherosclerotic cardio-
vascular disease (documented by clinical or unequiv-
ocal imaging); Diabetes with target organ damage or
at least three major risk factors or early type 1 dia-
betes long-duration (>20 years); severe chronic
kidney disease (glomerular filtration rate<30 ml/
kg/min), 10%; familial hypercholesterolaemia with
atherosclerotic cardiovascular disease or another
major risk factor; SCORE  10%
• High risk: markedly elevated single risk factors,
familial hypercholesterolaemia without other major
risk factors; diabetes without target organ damage
and duration 10 years or one additional risk
factor; SCORE 5-9%
• Moderate risk: young patients type 1 diabetes <35
years of age; type 2 diabetes with age until 50 years
old, diabetes duration <10 years without other risk
factors; SCORE 1–4%
• Low risk: SCORE<1%.
Dyslipidaemia treatment:
• Healthy diet, weight control, regular physical activ-
ity, smoking cessation (without weight gain)
• Medication according to cardiovascular risk and
expected outcomes achievement.
Expected outcomes:
• Expected outcomes are according to the cardiovas-
cular atherosclerotic risk level and LDL-C.
Consequently, the targeted approach to lipid man-
agement is primarily aimed at reducing atheroscle-
rotic risk by substantially lowering LDL-C.
LDL-C goals (primary):
• Very-high risk: a therapeutic regimen that achieves
50% LDL-C reduction from baseline and an LDL-
C goal of <1.4 mmol/l (<55 mg/dl). No current
statin use is likely to achieve this goal, which
requires high-intensity LDL-lowering combination
therapy
• High risk: a therapeutic regimen that achieves
50% LDL-C reduction from baseline and an
LDL-C goal of <1.8 mmol/l (<70 mg/dl)
• Moderate risk: a goal of <2.6 mmol/l (<100 mg/dl)
• Low risk: a goal of <3.0 mmol/l (<116 mg/dl)
• For patients with atherosclerotic cardiovascular dis-
ease who experienced a second vascular event within
2 years (not necessarily of the same type as the first
event) while taking maximally tolerated statin ther-
apy, an LDL-C goal of <1.0 mmol/a (<40 mg/dl)
may be considered.
Non-HDL-C goals (secondary):
• Very-high risk <2.2 mmol/l (<85 mg/dl)
• High-risk <2.6 mmol/l(<100 mg/dl)
• Moderate risk people <3.4 mmol/l (<130 mg/dl).
Apoprotein B (ApoB) goals (secondary):
• Very high risk <65 mg/dl
• High risk <80 mg/dl
• Moderate risk <100 mg/dl
Triglycerides:
• no goal, but <1.7 mmol/l (<150 mg/dl) indicates
lower risk and higher levels indicate a need to look
for other risk factors.36
IIIB.a.7. Blood pressure monitoring and management35
Blood pressure assessment:
• Measurement at rest, considering as cut-point for
(HTN), office systolic blood pressure (SBP) 140
mmHg and/or diastolic blood pressure (DBP) 90
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mm Hg, equivalent to a 24-hour ambulatory blood
pressure monitoring average of 130/80 mm Hg, or a
home blood pressure monitoring average 135/85 mm
Hg
• Classification of blood pressure: high-normal blood
pressure (BP) (130–139/85-89 mm Hg), grade 1
HTN (140–159/89–99 mm Hg), grade 2 HTN
(160–179/100–109 mm Hg), grade 3 HTN (160–
179/100–109 mm Hg)
• Attention to visit-to-visit BP variability which is
associated with increased cardiovascular and renal
disease risk.
Blood pressure control:
• Lifestyle intervention (sodium restriction, alcohol
moderation, healthy eating, regular exercise, weight
control and smoking cessation) in high-normal BP
and hypertension (grades 1, 2, 3)
• Drug treatment consideration in high normal BP, in
very-high-risk patients with cardiovascular disease
(CVD)
• Drug treatment in hypertension (grades 1,2,3), initi-
ating two drugs most of the times, except for frail
old and very old patients, which should begin on
monotherapy.
Expected outcomes:
• Office BP <140/90 mm Hg in all patients (targeted
to 130/80 mm Hg or lower in most patients when
treatment is well tolerated).
• Office SBP in the range 120–129 mm Hg in most
<65 years patients receiving BP-lowering drugs.
• Office SBP targeted to a range of 130–139 mm Hg in
older patients (aged 65 years) receiving BP-
lowering drugs, with close monitoring of adverse
effects.
• Office DBP target of <80 mm Hg for all hyperten-
sive patients, independent of the level of risk and
comorbidities.
• Office BP 120–129/80 mm Hg in people with
diabetes.
• Office pressure in people with chronic kidney disease
130–139/90 mm Hg.
• SBP should not be decreased: below 120 mm Hg in
diabetic and in patients with 65 years; below 130
mm Hg in chronic kidney disease patients.
III.B.a.8. Diabetes management
• Intensive behavioural lifestyle intervention pro-
gramme to achieve and maintain loss of body
weight and glycaemic, BP and lipid goals control
• Individualised meal plan with reduced calories, in
appropriate portion sizes
• Increase moderate-intensity physical activity (such
as brisk walking) to at least 150 min/week
• Pharmacological treatment
• Diabetes self-management education and support
programmes.
Expected outcomes:
• >HbA1c goal <7% (53 mmol/mol) in general for
non-pregnant adults; preprandial capillary plasma
glucose 80–130 mg/dl (4.4–7.2 mmol/l); peak post-
prandial capillary plasma glucose 180 mg/dl (10.0
mmol/l). More or less stringent glycaemic goals may
be appropriate for individual patients. Goals should
be individualised based on duration of diabetes, age/
life expectancy, comorbid conditions, knownCVDor
advanced microvascular complications, hypoglycae-
mia unawareness, and individual patient considera-
tions. Postprandial glucose may be targeted if
HbA1c goals are notmet despite reaching preprandial
glucose goals. Postprandial glucose measurements
should be made 1–2 h after the beginning of the
meal, generally peak levels in patients with diabetes
• HbA1c goals as 6.5% (48mmol/mol) for selected indi-
vidual patients (if this can be achieved without signifi-
cant hypoglycaemia or other adverse effects of
treatment as in polypharmacy) with short duration
of diabetes, type 2 diabetes treated with lifestyle or
metformin only, long life expectancy, or no significant
CVD.
• HbA1c goals as 8% (64 mmol/mol) may be appro-
priate for patients with a history of severe hypogly-
caemia, limited life expectancy, advanced
microvascular or macrovascular complications,
extensive comorbid conditions, or long-standing dia-
betes in whom the goal is difficult to achieve despite
diabetes self-management education, appropriate
glucose monitoring, and effective doses of multiple
glucose-lowering agents including insulin.
• Loss of 7% of initial body weight (at least).61–63
III.B.a.9. Smoking cessation
• Education and encouragement to smokers not to
smoke through special cessation and motivational
programmes, pharmacotherapy, structured follow-
up and coaching, behavioural advice.
Expected outcomes:
• Long-term abstinence from smoking:
III.B.a.10. Psychosocial management
• Screening for depression, anxiety, anger, hostility,
social isolation, occupational or family distress,
sexual dysfunction, substance abuse
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• Intervention in small groups or individual level,
though counselling and education on heart disease,
stress management, relaxation techniques and life-
style changes, as vocational counselling.
This component is fundamental in CR, relating to
quality of life, adherence and prognosis. It includes
patients evaluation and interventions by psychologists
and/or psychiatrists (see Table 6).
Psychological baseline evaluation of all patients will
allow the screening of psychosocial wellbeing such as
depression, anxiety, anger, hostility and personality
disturbances, through interview and questionnaires.
Patients identified to have psychological disturban-
ces will be directed to psychologist consultation and
with psychiatric disease to psychiatric consultation.
Psychological intervention (psychologist or psychia-
trist) will use appropriate behavioural techniques such
as cognitive-behavioural techniques (CBTs) or behav-
ioural activation for lifestyle modification, cardiovas-
cular risk factor control and adherence to
pharmacological and non-pharmacological therapy,
sexual dysfunction, smoking cessation management
and relaxation techniques when indicated. Other
approaches to improve care and outcomes might be
used, like yoga, tai-chi and dancing.
Expected outcomes:
• Minimising psychosocial problems and acquisition
of stress management skills, improved psychosocial
wellbeing and health-related quality of life evaluated
by validated tools.
III.B.a.11. Vocational advice
Return to prior activities need to be discussed with the
patient and family and promoted, unless there is a
contra-indication.
The social worker, or a generalist doctor, according
to different countries, should support the reintegration
in work of the patient or, in case he is disabled for that
work, attest his incapacity and suggest (if incapacity is
partial) an alternative type of work. In case of econo-
mic incapacity for the acquisition of fundamental med-
ication and transport to the CR centre, economic
support should be provided by the social assistant.
The social worker will guide those patients who are
disabled and need to reach specific institutions or get
home-based assistance (see Table 7).
Use most recent evidence to achieve optimal reinte-
gration of acute coronary syndrome patients on return-
ing to work. 64
A social worker should be available to help resolving
social and economical problems that affect transporta-
tion to the CR programme, consultations, examina-
tions and also medication adherence, among others.
Especially old, low-income and low-level education
patients may benefit from this support.
III.B.a.12. Education
Education and information need careful communica-
tion. Patients should be taught and empowered in
order to manage their own disease. A list of topics
needs to be covered by the CR team members.
Counselling for lifestyle modification (healthy) and
risk factor control should be performed by all the mem-
bers of the multidisciplinary CR team. Clear informa-
tion in plain language should be used, according to the
characteristics and literacy of the patient. Spouses and
partners of patients should be considered to participate
in educational and counselling session regularly.
Health behavioural change and education need to
include all relevant core components, like the increase
of physical activity, adequate healthy diet with individ-
ual adjustments, risk factors management and proper
medication intake (see Table 8).
Expected outcomes:
Table 7. Social support recommendations.
Patient support in work reintegration
Economic support if necessary for medication and consultations
Orientation to institutions or home support for those patients
who are disabled
Table 8. Education, information and recommendations.
Lifestyle risk factor management:
Physical activity increase and exercise
Healthy eating
Tobacco cessation and relapse prevention
Cardiovascular disease information: aetiology, mechanisms,
clinical presentations, therapeutics, prognosis
Medical risk management: risk factor targets and ways to control,
counselling (sports, exercise, return work, driving)
Psychosocial health management
Long-term adherence strategies to pharmacological and non
pharmacological therapy
Table 6. Psychological/psychiatric evaluation and intervention.
Evaluation of all patients by a psychologist using appropriate
questionnaires prior to the start of cardiac rehabilitation
Referral of patients with psychological problems to a psycholo-
gist for psychological intervention
Referral to psychiatrist of patients with depression, anxiety,
stress, other psychiatric disturbances for diagnosis confirma-
tion and therapeutic intervention
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• Adherence to lifestyle changes, to exercise pro-
gramme and to medication.
III.B.a.13. Long-term strategies
Strategies are necessary to maintain long-term the
effects of CR:
• Follow-up in consultations, by phone and/or by
mail, by a doctor and/or nurse
• Follow-up with coaching and motivational techni-
ques, by a psychologist and/or a nurse
• Long-term scheduled single education and exercise
sessions
• Referral to community CR programmes (phase 3 or
long-term CR).
Patients should have previous empowerment
through educational programmes for long-term
adherence, but maintaining the contact with the
patients will reinforce habit change, risk factor man-
agement and medication adherence.
The follow-up in person during medical consulta-
tions, and by phone and/or by mail by a nurse is essen-
tial. Also, the follow-up with coaching and use of
motivational techniques, by a psychologist and/or a
nurse are important.
If possible, the schedule at the end of phase 2 CR of
single education and exercise sessions (at 6 months or 1
year intervals), might help maintaining the adherence
to healthy lifestyle and risk factors control.
Also, after ending phase 2, the patient should be
referred to a community-based long- term CR pro-
gramme (phase 3). A long-term programme is funda-
mental for maintaining phase-2 CR gains.
Expected outcomes:
• Long-term adherence to medication and to a healthy
lifestyle.
III.B.a.14. CR results evaluation
CR programmes need to include patients’ gains evalu-
ation after the phase 2 programme conclusion (see
Table 9).
After the programme completion, symptoms and
risk factors need assessment; blood analysis, exercise
test, echocardiogram and other examinations (e.g.
Holter) need to be performed for evaluation of cardiac
function and functional capacity changes; several vali-
dated questionnaires should be completed to evaluate
the improvement in quality of life, status of depression
or anxiety, nutritional status; status of physical activity
should be checked. A discharge letter after phase 2 to
the attendant physician with a strategic long-term pre-
vention plan, taking into account the active problems,
is essential.
Expected outcomes:
• Objective quantification of all gains after phase 2 –
CR programme – clinical, psychological, quality of
life, functional capacity, risk factors control, nutri-
tional status improvement.
IV. Quality metrics/indicators
Similar to the quality indicators, described by the
American College of Cardiology (ACC) 2018 clinical
performance and quality measures for CR,65 quality
indicators of the Canadian Society of
Rehabilitation66,67 and BACR quality indicators;68
the EAPC SP/CR section defined several quality
Table 9. CR results evaluation after.
Symptoms and risk factors evaluation
Exercise testing, echocardiogram and blood analysis – functional
capacity, cardiac function, arrhythmias, risk factors control
Quality of life questionnaire and other specific questionnaires,
e.g. anxiety and depression
Nutritional status and physical activity evaluation
Table 10. Quality indicators.
Quality indicators
% Patients eligible to CR referred after discharge to CR pro-
gramme (>80%)
% Eligible patients to CR, enrolled after discharge (>50%)
Median waiting time from referral to start of CR (within 14–28
days)a
% CR uptake (minimal 24 sessions with an aim of 36 sessions)
% CR adherence (>75% completes the programme)
% Drop-out (<25%)
% Patients with a recorded assessment before starting CR
(>80%)
% Patients with a recorded assessment after starting CR (>80%)
% Pharmachological adherence improvement (>80%)
% Weight reduction in obese and overweight (>5%)b
% Functional capacity improvement (>5%)
% Muscle strength improvement (>5%)
% Quality of life score improvement (>10%)
% Anxiety/depression score improvement (>10%)
% Smoking cessation (>50%)
% BP control in hypertension (>50%)
% Lipids control in dyslipidaemia (>50%)
% Glycaemic control in diabetes (>50%)
BP: blood pressure; CR: cardiac rehabilitation; MI: myocardial infarction.
a14 Days for MI and 28 days for CABG.
bExcept for those on smoking cessation where maintenance of weight is
acceptable.
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indicators (see Table 10). Most of them are included as
KPIs in the EAPC accreditation programme. Both
internal (within the CR centre) and external evaluation
should be performed on a cyclic, repetitive and period-
ical basis. The EAPC Accreditation Programme
Evaluation Committee will be responsible for periodi-
cal re-evaluation and re-accreditation of European CR
centres, compliant with the minimal/optimal standards
and quality indicators defined in this position
statement.
V. Conclusion
Heterogeneity persists amongst different Cardiovascular
Rehabilitation Centres in Europe, despite of CR evi-
dence-based solid data published in many scientific
documents.
This position statement, elaborated by the EAPC
Secondary Prevention and Rehabilitation Section,
defines the minimal and optimal CR standards and in
addition sets the relevant CR quality indicators to date,
aiming to improve preventive cardiology practice and
consequently cardiovascular health.
Compliance of the European Cardiovascular
Rehabilitation centres with these recommendations
will certainly improve CR standardization process
and allow to measure CR quality of care improvement
in Europe.
EAPC accreditation of Secondary Prevention and
Cardiac Rehabilitation centres of the ESC members
and ESC affiliated countries, is expected to effectively
promote a higher quality and more homogeneous car-
diovascular rehabilitation in Europe and beyond.
VI. Areas for future research
Future research should include:
• The assessment of the impact of the EAPC
Secondary Prevention and Cardiac Rehabilitation
centres accreditation programme on CR quality of
care
• The potential improvement of future SP/CR accred-
itation programmes
• Standards for an EAPC european cardiovascular
rehabilitation database
• Formal benchmarking analysis of the provision of
CR in Europe by centres.
• Standards and quality criteria for Home-
based Cardiovascular Rehabilitation including
Telerehabilitation.
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